# NEVIRAPINE
> **ANDA207064** · Abbreviated New Drug Application (Generic) · Sponsor: CIPLA LIMITED · Approved 2015-06-30
## Drug
- **FDA Application Number:** ANDA207064
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** NEVIRAPINE
- **Generic name:** Nevirapine
- **Active ingredients:** NEVIRAPINE
- **Dosage form:** TABLET, EXTENDED RELEASE
- **Route:** ORAL
- **Marketing status:** None (Tentative Approval)
- **Sponsor:** CIPLA LIMITED
- **First approval:** 2015-06-30
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207064)
---
*AI Analytics · CC0 1.0*